SHARE:  

View as Webpage

AlternateTop_logo.jpg

Camber Pharmaceuticals Launches Generic Gastrografin®

Piscataway, NJ, October 15, 2024 – Camber Pharmaceuticals is pleased to announce the addition of Diatrizoate Meglumine and Diatrizoate Sodium Solution, USP to its product line. Camber is the first and only generic option for Gastrografin®.


Diatrizoate Meglumine and Diatrizoate Sodium Solution, USP is indicated for radiographic examination of segments of the gastrointestinal tract (esophagus, stomach, proximal small intestine, and colon). The preparation is particularly indicated when a more viscous agent such as barium sulfate, which is not water-soluble, is not feasible or is potentially dangerous.


Diatrizoate Meglumine and Diatrizoate Sodium Solution, USP may also be used as an adjunct to contrast enhancement in computed tomography of the torso (body imaging); the preparation is indicated, in conjunction with intravenous administration of a radiopaque contrast agent, when unenhanced imaging may not provide sufficient definition in distinguishing normal loops of bowel from adjacent organs or areas of suspected pathology.


Diatrizoate Meglumine and Diatrizoate Sodium Solution, USP is available in 66-10% strength and in the following bottles sizes:


30 mL x 24 Single -Dose Vials

120 mL x 12 Single-Dose Vials


To learn more about Diatrizoate Meglumine and Diatrizoate Sodium Solution, USP  please visit https://www.camberpharma.com/dmds

Camber Pharmaceuticals is a fully integrated pharmaceutical company. Its parent company, Hetero, of Hyderabad, India, is one of the world’s leading API and finished dose manufacturers. Camber is committed to bringing the highest quality generic pharmaceuticals to consumers and improving quality of life through cost-effective medications.   

Camber-Logo-300-x-300.jpg

For more information, please contact your Sales Representative or Customer Service at customerservice@camberpharma.com | 732.529.0430

AlternateBottom.jpg